The Institute of Molecular Medicine (IMM) celebrates its 10th anniversary. It has over 660 employees, and now it has 500 researchers, of whom 206 have PhDs and 30 are foreigners. The IMM has 38 research units and three start-ups (technology-based companies at development stage), encompassing research groups in the fields of rheumatic diseases, neurosciences, vascular diseases, movement, dementia, immuno-allergology, and cancer. The research carried out at the IMM is clinically oriented to diseases of the 21st century, such as cancer, Alzheimer’s disease, cardiovascular diseases (stroke), rheumatic diseases (rheumatoid arthritis), infectious diseases (HIV/AIDS), and malaria, among others. Currently the IMM has […]